Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 172897, 9 pages
http://dx.doi.org/10.1155/2012/172897
Review Article

Fenretinide (4-HPR): A Preventive Chance for Women at Genetic and Familial Risk?

Division of Cancer Prevention and Genetics, European Institute of Oncology, 20141 Milan, Italy

Received 5 October 2011; Revised 12 December 2011; Accepted 15 December 2011

Academic Editor: Dianne R. Soprano

Copyright © 2012 Massimiliano Cazzaniga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [20 citations]

The following is the list of published articles that have cited the current article.

  • Saba Haq, Shadan Ali, Ramzi Mohammad, and Fazlul H. Sarkar, “The complexities of epidemiology and prevention of gastrointestinal cancers,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 12556–12572, 2012. View at Publisher · View at Google Scholar
  • Massimiliano Cazzaniga, and Bernardo Bonanni, “Breast Cancer Chemoprevention: Old and New Approaches,” Journal of Biomedicine and Biotechnology, vol. 2012, pp. 1–15, 2012. View at Publisher · View at Google Scholar
  • Veena Sharma, and Ritu Paliwal, “Potential Chemoprevention of 7,12-Dimethylbenz[a]anthracene Induced Renal Carcinogenesis by Moringa oleifera Pods and Its Isolated Saponin,” Indian Journal of Clinical Biochemistry, vol. 29, no. 2, pp. 202–209, 2013. View at Publisher · View at Google Scholar
  • Nirupama Sabnis, Suraj Pratap, Irina Akopova, Paul W Bowman, and Andras G Lacko, “Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma.,” Frontiers in pediatrics, vol. 1, pp. 6, 2013. View at Publisher · View at Google Scholar
  • C. Sergiampietri, and R. Tana, “Alternatives to risk-reducing surgery for ovarian cancer,” Annals of Oncology, vol. 24, pp. 47–53, 2013. View at Publisher · View at Google Scholar
  • Mark F. Naylor, David M. Thompson, Stan Lightfoot, and Doris Mangiaracina Benbrook, “Anti-Cancer Activities and Interaction of Imiquimod and Flex-Het, SHetA2, in Melanoma and Ovarian Cancer,” Journal of Cancer Therapy, vol. 04, no. 06, pp. 7–19, 2013. View at Publisher · View at Google Scholar
  • Engin Ulukaya, Mehmet Sarimahmut, Buse Cevatemre, Ferda Ari, Azmi Yerlikaya, and Konstantinos Dimas, “Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro,” Biomedicine & Pharmacotherapy, 2014. View at Publisher · View at Google Scholar
  • Christina Y. Yim, Pingping Mao, and Michael J. Spinella, “Headway and Hurdles in the Clinical Development of Dietary Phytochemicals for Cancer Therapy and Prevention: Lessons Learned from Vitamin A Derivatives,” Aaps Journal, vol. 16, no. 2, pp. 281–288, 2014. View at Publisher · View at Google Scholar
  • Alessandra di Masi, Loris Leboffe, Elisabetta De Marinis, Francesca Pagano, Laura Cicconi, Cécile Rochette-Egly, Francesco Lo Coco, Paolo Ascenzi, and Clara Nervi, “Retinoic acid receptors and cancer: from molecular mechanisms to therapy,” Molecular Aspects of Medicine, 2014. View at Publisher · View at Google Scholar
  • Navdha Mittal, Saurabh Malpani, Matthew Dyson, Masanori Ono, John S. Coon, Julie J. Kim, Julian C. Schink, Serdar E. Bulun, and Mary Ellen Pavone, “Fenretinide: A Novel Treatment for Endometrial Cancer,” Plos One, vol. 9, no. 10, 2014. View at Publisher · View at Google Scholar
  • Fulvia Farabegoli, Marzia Govoni, Carmen Ciavarella, Marina Orlandi, and Alessio Papi, “A RXR Ligand 6-OH-11-O-Hydroxyphenanthrene with Antitumour Properties Enhances (−)-Epigallocatechin-3-gallate Activity in Three Human Breast Carcinoma Cell Lines,” BioMed Research International, vol. 2014, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Senthilmurugan Ramalingam, Lalji Gediya, Puranik Purushottamachar, Hannah Mbatia, Andrew K. Kwegyir-Afful, Vidya P. Ramamurthy, and Vincent C.O. Njar, “First Mnks degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines,” Oncotarget, vol. 5, no. 2, pp. 530–543, 2014. View at Publisher · View at Google Scholar
  • Iván P. Uray, Ethan Dmitrovsky, and Powel H. Brown, “Retinoids and Rexinoids in Cancer Prevention: From Laboratory to Clinic,” Seminars in Oncology, 2015. View at Publisher · View at Google Scholar
  • Michael J. Spinella, Sarah J. Freemantle, and Ethan Dmitrovsky, “Advances in the Use of Retinoids in Cancer Therapy and Prevention,” The Retinoids, pp. 557–574, 2015. View at Publisher · View at Google Scholar
  • Barbara Bassani, Desirèe Bartolini, Arianna Pagani, Elisa Principi, Douglas M. Noonan, Antonino Bruno, Massimo Zollo, and Adriana Albini, “Fenretinide (4-HPR) targets caspase-9, ERK 1/2 and the Wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids,” PLoS ONE, vol. 11, no. 7, 2016. View at Publisher · View at Google Scholar
  • Danielle Liddle, “Fenretinide,” Encyclopedia of Cancer, pp. 1706–1708, 2017. View at Publisher · View at Google Scholar
  • Eugenia Poliakov, William Samuel, Todd Duncan, Danielle B. Gutierrez, Nathan L. Mata, and T. Michael Redmond, “Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1,” PLoS ONE, vol. 12, no. 4, 2017. View at Publisher · View at Google Scholar
  • Valentina Appierto, Paola Tiberio, Elena Cavadini, Loredana Cleris, Sabrina Dallavalle, Loana Musso, and Maria G. Daidone, “Sodium 4-Carboxymethoxyimino-(4-HPR) a Novel Water-Soluble Derivative of 4-Oxo-4-HPR Endowed with In Vivo Anticancer Activity on Solid Tumors,” Frontiers in Pharmacology, vol. 8, 2017. View at Publisher · View at Google Scholar
  • Melody Saikali, Rana Abdel-Samad, Claudio Pisano, Rabih Talhouk, Patrick Aouad, Sabreen Fostok, Leeanna El-Houjeiri, and Nadine Darwiche, “Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models,” Anti-Cancer Drugs, vol. 28, no. 7, pp. 757–770, 2017. View at Publisher · View at Google Scholar
  • Ruth. R. Magaye, Feby Savira, Yue Hua, Darren J. Kelly, Christopher Reid, Bernard Flynn, Danny Liew, and Bing H. Wang, “The role of dihydrosphingolipids in disease,” Cellular and Molecular Life Sciences, 2018. View at Publisher · View at Google Scholar